Metformin treatment linked to slowed cognitive decline

dementia
Credit: CC0 Public Domain

Metformin is the first-line treatment for most cases of type 2 diabetes and one of the most commonly prescribed medications worldwide, with millions of individuals using it to optimize their blood glucose levels.

A new research study, conducted over six years in the Sydney Memory and Ageing Study in 1037 Australians (aged 70 to 90 years old at baseline), has revealed an additional effect: individuals with type 2 who used metformin experienced slower cognitive decline with lower rates than those who did not use the medication.

The findings provide new hope for a means of reducing the risk of dementia in individuals with…

Read more…